HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
about
PACAP27 is protective against tat-induced neurotoxicityClinical factors related to brain structure in HIV: the CHARTER studyOligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive DisordersHIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseNatural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceEvolving clinical phenotypes in HIV-associated neurocognitive disordersNovel approaches and challenges to treatment of central nervous system viral infectionsExosomes as mediators of neuroinflammationRoles and functions of HIV-1 Tat protein in the CNS: an overviewNeurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapyMonocytes as regulators of inflammation and HIV-related comorbidities during cARTProtease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HANDCortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaineHIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersDopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesisInteraction of paroxetine with mitochondrial proteins mediates neuroprotection.The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewUntangling the Gordian knot of HIV, stress, and cognitive impairmentAssociations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profilesThe NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytesComputational modeling reveals distinct effects of HIV and history of drug use on decision-making processes in womenEpigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependenceDopamine receptor activation increases HIV entry into primary human macrophagesThe National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studiesSystems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's diseaseGene expression profiles and protein–protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementiaHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Ageing and inflammation in patients with HIV infection.Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future DirectionsExpression of gp120 in mice evokes anxiety behavior: Co-occurrence with increased dendritic spines and brain-derived neurotrophic factor in the amygdala.Getting to 90-90-90 in paediatric HIV: What is needed?Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial.The increasing chronicity of HIV in sub-Saharan Africa: Re-thinking "HIV as a long-wave event" in the era of widespread access to ARTThe longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells.Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat.Lower cognitive reserve in the aging human immunodeficiency virus-infected brain.
P2860
Q24293525-D532186B-4D97-4DA2-B15B-4F6FBB37E102Q24603224-D831FD5B-E534-4CFF-BE30-267372EB1873Q26741723-53E89F61-2296-4348-95C9-2E889FB3DB97Q26766448-CD08E2F7-079D-4785-83F7-CBBFEE92E904Q26770397-D52D5D38-55DD-4F3B-98C7-FE093434612EQ26770401-B30E7354-BF47-4008-A03B-CF90FFE57D53Q26825762-CFB29E09-A727-47BF-A36F-57E8E4B775BFQ26859192-15FB8BE4-2533-4857-969E-919EA6DF558BQ26862449-4D742CE0-F285-4417-B9CD-66B2050DFB39Q26865141-1F8E4504-07A3-4AC1-965E-7CD58438B477Q26996314-398533D0-AFC7-4833-BA7A-1C52CCBD700CQ27000422-BE7E0C42-086A-4E78-A8C3-FC0F2C6B5A40Q27006827-497C0A0D-18DB-42E0-892C-39F88FBF485EQ27011426-292B1391-78DD-48D4-96BC-F2B2DBF3D30BQ27013928-0560FF2F-AE06-4171-AF49-7576CFA4803DQ27015965-1F804A79-4D75-41B4-810E-097B68EDE628Q27025573-40AEF836-CBE3-4D8F-889C-50C76D6B3471Q27316037-A60F3467-8BC7-4950-80CA-E841D3BC408DQ27339182-3D3D580D-E792-458F-8E56-201BEB6F96CAQ28066725-D7A1562E-DE2A-4C1A-94DC-1AF0E2D0BA08Q28067483-25B5BDA6-AAE6-4379-BC4F-825932F81740Q28481666-CF7B7318-2920-4602-A403-9D71F9030620Q28486204-63C9E4C2-0D7B-458A-B598-39055FA9FEEBQ28535185-113B5A7E-8B07-45F6-BA44-0777F96CDAFFQ28541100-26EF5148-CEC4-4463-B66E-CA1256C4DB3BQ28543414-E50D530A-988E-4C91-900F-A47BB0C4234CQ28645981-265E8FA4-A901-4F59-AFB3-7E850E3F0D26Q28709047-C55A2BD5-755B-4C71-A972-1D26F61DF40FQ30053318-6E34DEF2-F3E6-4488-831B-9E0EA07813B0Q30234305-528CF161-8E5A-43A4-9A9F-561A10DC17AFQ30244296-742F204F-2C4A-458D-A994-FE00C79AD02CQ30244921-2F508A97-3DFC-4C0B-B1D1-C3368FA35820Q30357525-329851E0-5F99-4F77-9518-E5203DBDC804Q30385352-F794BAFE-D574-4F14-AA22-8F41F3B92DA7Q30391907-85F7DCCB-56E9-459F-8085-9A1513137CEBQ30408451-BA6FC8B4-AF69-4C94-8DB7-7D90524AF360Q30410418-C6B5CB27-4AFD-4015-91EF-4901D4FDC85CQ30413065-080EDC05-1AC3-4160-8E6F-ABD6855EA9F5Q30431943-6442F4B4-4E31-4DC8-A104-B8F7D6D39DAAQ30440212-99DA4CB5-3850-41EB-9332-00F90C84B0E6
P2860
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV-associated neurocognitive ...... rates, nature, and predictors
@ast
HIV-associated neurocognitive ...... rates, nature, and predictors
@en
HIV-associated neurocognitive ...... rates, nature, and predictors
@nl
type
label
HIV-associated neurocognitive ...... rates, nature, and predictors
@ast
HIV-associated neurocognitive ...... rates, nature, and predictors
@en
HIV-associated neurocognitive ...... rates, nature, and predictors
@nl
prefLabel
HIV-associated neurocognitive ...... rates, nature, and predictors
@ast
HIV-associated neurocognitive ...... rates, nature, and predictors
@en
HIV-associated neurocognitive ...... rates, nature, and predictors
@nl
P2093
P2860
P50
P3181
P1476
HIV-associated neurocognitive ...... rates, nature, and predictors
@en
P2093
Ann C Collier
Anthony Gamst
Benjamin B Gelman
Christina M Marra
David B Clifford
David M Simpson
Donald R Franklin
Ian Abramson
J Allen McCutchan
J Hampton Atkinson
P2860
P2888
P3181
P356
10.1007/S13365-010-0006-1
P407
P50
P577
2011-02-01T00:00:00Z
P5875
P6179
1041512662